Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | RGT-61159 |
| Synonyms | |
| Therapy Description |
RGT-61159 inhibits the transcription factor c-Myb, potentially leading to decreased tumor cell proliferation and inhibition of tumor growth (J Clin Oncol 42, 2024 (suppl 16; abstr 6107)). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| RGT-61159 | RGT 61159|RGT61159 | RGT-61159 inhibits the transcription factor c-Myb, potentially leading to decreased tumor cell proliferation and inhibition of tumor growth (J Clin Oncol 42, 2024 (suppl 16; abstr 6107)). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06462183 | Phase I | RGT-61159 | Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC) | Recruiting | USA | CAN | 0 |